| Vol. 9.38 – 1 October, 2020 |
| |
|
|
| Single-cell transcriptome analysis identified brain-derived neurotrophic factor as a STAT3 target gene with newly accessible chromatin in a unique population of regenerating AT2 cells. [Nature Cell Biology] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors investigated the dynamic toxicities of naphthalene-derived secondary organic aerosol in a human bronchial epithelial cell line and identified the chemical components responsible for toxicities. [Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Investigators showed abnormal upregulation of tumor protein p63 (TP63) and downregulation of miR-184 in idiopathic pulmonary fibrosis. Transforming growth factor beta 1 stimulation of BEAS-2B and A549 cell lines significantly increased the protein levels of Tp63, alpha-smooth muscle actin, and vimentin, but decreased EpCAM protein levels, and promoted viability of both BEAS-2B and A549 cell lines. [Laboratory Investigation] |
|
|
|
| Scientists investigated the radioprotective effects and the underlying mechanism of the standardized herbal extract PM014 on radiation-induced lung fibrosis. [Scientific Reports] |
|
|
|
| Researchers used a randomized crossover experiment to estimate the effects of ozone exposure on genome-wide DNA methylation of target bronchial epithelial cells, using 17 volunteers, each randomly exposed on two separated occasions to clean air or 0.3-ppm ozone for two hours. [Scientific Reports] |
|
|
|
| Scientists studied the role of homeobox protein B13 (HOXB13) in cytotoxicity caused by hydrogen peroxide in human lung epithelial A549 cells. The knockdown of HOXB13 reduced hydrogen peroxide-induced cytotoxicity; however, this phenomenon was largely absent in the presence of antioxidants. [Toxics] |
| |
|
|
| The authors established a three‐dimensional murine bronchioalveolar lung organoid model that allowed clonal expansion and self‐organization of FACS‐sorted bronchioalveolar stem cells upon co‐culture with lung‐resident mesenchymal cells. [EMBO Journal] |
|
|
|
| Researchers showed that increased fibroblast growth factor receptor 1 (FGFR1) promoted tumorigenic progression in precancerous neuroendocrine cells and was required for small cell lung cancer development in vivo. [Cancer Research] |
|
|
|
| Scientists determined that microRNA-3613-5p plays a crucial role in RELA-mediated post-transcriptional regulation of lung adenocarcinoma cell proliferation. [Molecular Therapy-Nucleic Acids] |
|
|
|
| A549 and H1299 cell lines were screened out and their parent cells and drug-resistant cells were co-cultured with human bone marrow mesenchymal stem cells-derived exosomes that had been transfected with miR-193a mimic or si-LRRC1 to detect the colony formation, migration, apoptosis, invasion and proliferation of non-small cell lung cancer cells. [Cell Death & Disease] |
|
|
|
| Researchers investigated the clinicopathologic significance of microRNA-130b in lung adenocarcinoma and analyzed its cancer-specific functions. [Laboratory Investigation] |
|
|
|
|
| EGFR mutations are the most common oncogenic drivers in NSCLC. Significant developments have taken place which highlight the differences in tumor biology that exist between the mutant and wild-type subtypes of NSCLC. [Pharmaceuticals] |
|
|
|
|
| Windtree Therapeutics, Inc. announced that FDA has accepted its Investigational New Drug application for a Phase II clinical trial studying lyo lucinactant, its KL4 surfactant drug, in COVID-19 associated lung injury and acute respiratory distress syndrome patients. [Windtree Therapeutics, Inc.] |
|
|
|
| Vertex Pharmaceuticals Incorporated announced the FDA approved KALYDECO® for use in children with cystic fibrosis ages four months to less than six months old who have at least one mutation in their cystic fibrosis transmembrane conductance regulator gene that is responsive to KALYDECO based on clinical and/or in vitro assay data. [Vertex Pharmaceuticals Incorporated] |
|
|
|
|
| May 16 – May 21, 2021 Lucca, Italy |
|
|
|
|
|
| University of California, San Diego – La Jolla, California, United States |
|
|
|
| Old Dominion University – Norfolk, Virginia, United States |
|
|
|
| NYU Langone Health – New York, New York, United States |
|
|
|
| Institut Mondor de Recherche Biomédicale (IMRB) – Creteil, France |
|
|
|
| National Heart and Lung Institute – London, United Kingdom |
|
|
|
|